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Introduction
The relationship between adiposity and asthma has been extensively investigated in children and adults 1 2 . A systematic review and meta-analysis of prospective observational studies has summarized that there is a similar association between adiposity, measured by body mass index (BMI), and asthma risk in women and men 1 . Later, in a prospective cohort study using the Norwegian HUNT population we confirmed this association in both sexes 3 . We also found an association between adiposity measured by waist circumference (WC) and asthma risk in women after adjustment for BMI 3 . However, findings of the relationship between waist size independent of BMI and asthma risk have been inconsistent in observational studies 4 5 .
Observational studies have limitations to assess causal association due to confounding and reverse causation. The Mendelian randomization (MR) approach attempts to overcome these limitations with the use of genetic variants that serve as instrumental variables for the exposure of interest 6 7 .
Two MR studies in children found genetically determined increase in BMI being associated with a higher risk of asthma 8 9 ; the magnitude of the effect of BMI, however, differed by sex. The studies also identified a stronger effect on non-atopic than atopic asthma and an association between genetically determined fat mass or waist-hip ratio (WHR) and asthma risk 8 9 . Two MR studies were performed in adults using the individual-level data 10 11 ; one study reported a 7% increase in risk for asthma associated with 1 kg/m 2 increase in genetically predicted BMI 10 , while the other reported a marginal association 11 . None of the studies in adults has evaluated the potential effect modification by sex. Nor have they evaluated if waist-hip ratio, a marker for central adiposity, plays a causal role in asthma risk independently of BMI 10 11 . Moreover, a possible causal association of adiposity with asthma symptom control has not been investigated in the previous MR studies.
Adults with asthma have a higher prevalence of obesity than their healthy peers 12 . This may be explained by less physical activity among adults with asthma 13 . An evaluation of the reverse causation, i.e. if asthma leads to increased adiposity, is thus warranted. In a large and homogenous population of adults, we aimed to investigate 1) if there was a causal association between adiposity and risk of asthma; 2) if there was effect modification by sex; 3) what was the magnitude of causal effect of adiposity on asthma by atopic status or by levels of asthma symptom control; and 4) if there was a potential reverse causation between asthma and the risk of adiposity. To achieve these aims, we performed a bidirectional one-sample MR study using the Norwegian HUNT population in which BMI and WHR were studied as markers of general and central adiposity, respectively.
Methods

Study population
The study was based on data from the second survey of the HUNT Study (HUNT2, 1995-97).
HUNT2 included 65227 subjects 20 years or older living in Nord-Trøndelag in Norway (participation rate 70%) 14 . All participants completed two general questionnaires regarding health, lifestyle and socio-economic status, and attended a clinical examination.
BMI, WHR and associated genetic variants
Body weight, height, and waist and hip circumferences were measured by trained nurses as described elsewhere 14 . Genotyping was performed using Illumina HumanCoreExome arrays 15 . Seventy-seven single nucleotide polymorphisms (SNPs) were selected as instrumental variables for BMI based on a large genome-wide association study (GWAS) from the GIANT consortium 16 ; these SNPs were associated with BMI in adults of European ancestry at a genome-wide significance (p <5x10 -8 ), and the same SNPs were suggested for women and men. Data of two SNPs (rs12016871 and rs2033732) were not available in the HUNT study population. Two SNPs (rs13021737 and rs16951275) were associated with smoking status and were therefore excluded, leaving 73 SNPs as instruments for BMI in the current study.
An externally weighted BMI genetic risk score (GRS) was calculated by multiplying the number of BMI-increasing alleles for each variant by the variant's coefficient for BMI from the GIANT study 16 , and summing across the 73 variants. The BMI GRS showed an Fstatistic of 1122 and explained 2.0% of the variance in BMI in the HUNT2 Study.
Forty-nine SNPs were chosen as instruments for sex-combined WHR from adults of mainly European ancestry in the GIANT study at a p value <5x10 -8 17 ; sex-specific instruments were suggested including 48 SNPs for women and 33 SNPs for men at a p value <0.05. In HUNT2, data of 47, 46 and 32 SNPs were available and used to generate weighted WHR GRS for total, for women and for men respectively. None of these SNPs were associated with smoking or other potential confounders. The weights in GRS for total, women and men were coefficients for WHR from sex-combined or sex-specific analyses in the GIANT study 17 . The WHR GRS showed an F statistic of 174 and explained 0.3% of the variation in WHR in the total HUNT2 cohort. As HUNT was part of the GIANT study, we acknowledge that the calculation of weighted BMI and WHR GRS may be minimally biased. In the HUNT2 Study, seven asthma-associated SNPs from the GABRIEL study (p <5x10 -8 for asthma risk at all ages), a large GWAS on asthma in people with European ancestry 20 , were used in a weighted asthma GRS. The weighted asthma GRS explained about 0.4% (based on peudo R 2 ) of the variation in liability for ever asthma in the HUNT2 cohort. In a two-sample MR, 26 of 34 SNPs derived from a latest GWAS on asthma (p <5x10 -8 for adultonset asthma) 21 were used as instrumental variables for asthma. Data of the 26 SNPs were not accessible in the HUNT2 Study. Three of the 26 SNPs were in linkage disequilibrium (R 2 >0.1) with three of the seven SNPs used in the HUNT2 Study.
Asthma and associated genetic variants
Statistical analysis
First, we evaluated the potential causal BMI-asthma association among 56105 participants who had complete information on the BMI SNPs, BMI and asthma. We performed onesample MR analyses applying the Wald method 22 , with which MR-derived odds ratio (OR) and 95% confidence interval (CI) were calculated by the natural exponential function of the ratio of coefficient of GRS-outcome (asthma) association over coefficient of GRS-exposure (BMI) association. The coefficient of the GRS-asthma association was derived after adjustment for family history of asthma and education because there were associations of the BMI GRS with the two variables after a correction of multiple testing (Table S1 ). The coefficient of the GRS-BMI association was derived after adjustment for sex, age and agesquared 16 . The MR-derived OR corresponded to an effect of 1 standard deviation (SD) increase in genetically determined BMI.
Second, we evaluated the potential causal WHR-asthma association in 55671 of the 56105 adults who had complete information on the WHR SNPs, WHR and asthma. A similar approach was employed to calculate the MR-derived OR corresponding to 1 SD increase in genetically determined WHR. The coefficient of the GRS-asthma association was derived without adjustment for other variables as the WHR GRS was not associated with the potential confounders. The coefficient of the GRS-WHR association was derived after adjustment for sex, age, age-squared, and BMI 17 .
Third, we performed sensitivity analyses to test the robustness of the BMI-asthma association using the inverse-variance weighted (IVW) method and the MR-Egger method.
The IVW method combines ratio estimates derived from each genetic variant in a randomeffect meta-analysis model 23 . Additionally, we tested for heterogeneity among the 73 BMI SNPs by presenting the I 2 value in the IVW method 24 . The MR-Egger method is relatively robust to horizontal pleiotropy 25 , by which we calculated the intercept and 95% CI of the MR-Egger regression line 25 . Substantial horizontal pleiotropy is less likely if the intercept does not deviate markedly from zero. We also performed two-sample MR analyses to provide more evidence on the central adiposity-asthma relationship using the publicly accessible MR BASE 26 ; summary-level statistics were extracted from the GIANT Consortium on WHR/WC
Results
The characteristics of the HUNT2 cohort are described in Table 1 . The prevalence of ever asthma, doctor diagnosed asthma and doctor diagnosed active asthma in the HUNT2 population was 8.9%, 5.5% and 3.7%, respectively, and it was comparable in women and men. The MR estimates demonstrated a larger effect of BMI than the observational estimates, i.e. 36%-49% vs. 15%-17% higher ORs for asthma by the three definitions per 1 SD (4.1 kg/m 2 ) increase in BMI ( Table 2 ). Although the ORs per 1 SD (4.1 kg/m 2 ) in men were generally lower than those in women in the MR analyses, statistical tests showed little evidence of effect modification by sex (p>0.30 for all).
The proportion of atopic vs. non-atopic asthma was 36.9% vs. 63.1% for ever asthma, 47.0% vs. 53.0% for doctor diagnosed asthma and 48.1% vs. 51.9% for doctor diagnosed active asthma (Table 3 ). In the observational analyses, BMI was similarly associated with atopic and non-atopic asthma. However, the MR analyses showed larger ORs for non-atopic than atopic asthma (42%-72% vs. 18%-26% increased ORs for the three asthma definitions, respectively). The proportions of controlled vs. partly controlled doctor diagnosed active asthma were 26.9% vs. 72.0% ( Table 3 ). The effect of BMI on controlled asthma was similar to that on the partly controlled asthma. Similar patterns for asthma by atopic status or by levels of symptom control were observed in women and men despite the reduced statistical power by stratification (Tables S2 and S3 ).
There were positive associations between WHR and asthma in the total cohort and by sex in the observational analysis after additional adjustment for BMI (Table 4 ). However, the MR estimates showed little evidence of an association between genetically determined WHR and asthma, and no sex difference was found (p>0.27 for all).
Results from the IVW method were comparable with those from the Wald method (Table   S4 ). The I 2 values showed relatively low heterogeneity among the 73 BMI genetic variants.
Results from the MR-Egger method showed consistent evidence for ever asthma and doctor diagnosed asthma (Table S4) , and the corresponding intercepts did not deviate from zero.
However, the causal OR for doctor diagnosed active asthma was inconsistent and the intercept showed deviation from zero. The two-sample MR analyses showed little evidence on a causal association of WHR (Table S5) or WC (Table S6 ) with doctor diagnosed asthma.
Regarding the reverse asthma-adiposity relationship, genetically determined asthma was not associated with BMI (Table 5 ) or WHR (Table S7 ) in the HUNT2 Study. In two-sample MR of asthma on BMI/WHR we found similar results (Table S8 ).
Discussion
Main findings
We observed evidence of an association between genetically determined BMI and asthma in an adult population overall and by sex. The causal association appeared stronger for nonatopic than atopic asthma, but it was similar for controlled and partly controlled asthma.
Genetically determined WHR (after adjustment for BMI), however, was not associated with the asthma risk in this adult population. There was little evidence to support a reverse association between genetically determined asthma and the adiposity markers.
Comparison with previous studies
Our finding on the BMI-asthma causal association in the overall population was consistent with results from the previous MR studies in children and adults [8] [9] [10] [11] . A most recent twosample MR study using publicly available summary data further confirmed this causal direction in adults 27 . The similar association between genetically determined BMI and asthma in women and men in the current study was supported by prospective cohort studies 1 3 . However, it was not supported by the paediatric MR studies in which one reported a stronger causal association in girls 8 and the other reported a stronger association in boys 9 .
Regarding a stronger effect of BMI on non-atopic asthma, our finding was supported by the paediatric studies 8 9 , but not by an adult MR study that seemed to report a stronger effect on atopic asthma 10 . Misclassification of atopic status was possible in the latter study as it was defined by reported allergic rhinitis only 10 , whereas our definition was based on report of having allergic rhinitis in combination with reported use of allergy medication or with reported allergic symptoms.
We did not observe an association of genetically determined WHR with asthma. This was supported by results from the two-sample MR analyses on the WHR/WC-doctor diagnosed asthma associations using data from the MR BASE 26 . Genetically determined WHR showed an effect on asthma in a paediatric study 9 , suggesting that there might be different aetiologies for asthma in children as opposed to adults. No reverse association between genetically determined asthma and risk of adiposity was observed in the current and previous studies 9 27 .
Overall, our study supported a causal effect of higher BMI on increased risk of asthma in particular non-atopic asthma, but there was little evidence to suggest different effects on the levels of asthma symptom control. This indicated that increased BMI might play a more important role in causing rather than worsening asthma. Several mechanisms have been proposed for the obesity-asthma association, including mechanical mechanisms resulted from reduced lung volume and airway diameter due to obesity, and inflammatory mechanisms resulted from cytokines, chemokines and hormones produced mainly by abdominal adipocytes 28 . Our study suggested that mechanical restriction to the lung and airways due to obesity might be a major underlying mechanism for the association in adults 28 . This is supported by 1) a previous MR study in adults showing that genetically predicted BMI was associated with reduced lung function 10 and 2) we did not detect an effect of the central adiposity reflected by WHR.
Strengths and limitations
Our MR study has the following strengths. Apart from providing further evidence on a causal BMI-asthma association, we investigated the possibility of effect modification by sex in an adult population. We are the first to evaluate a potential causal association between WHR and asthma in adults. This is also the first attempt to investigate a potential causal effect of adiposity on asthma symptom control. In addition, our study is among the few to evaluate if reverse causation exists. Our study included a large homogenous population in which 97% were ethnic Norwegians 14 , which was favourable in terms of minimizing population stratification bias 23 . We also included the largest number of BMI SNPs (73 vs. [24] [25] [26] [27] [28] [29] [30] [31] [32] compared with the previous studies [8] [9] [10] [11] .
We studied thoroughly the three assumptions of the 73 SNPs being instrumental variables for BMI: 1) the F statistic of the BMI GRS indicated these SNPs being valid instruments 29 ;
2) the SNPs or GRS should not be associated with the measured confounders; and 3) there should be no horizontal pleiotropic effects of the BMI genetic variants on risk of asthma. To satisfy the second assumption, we first excluded two SNPs (rs13021737 and rs16951275) that were associated with smoking status, and further adjusted for family history of asthma and education when calculating the MR-derived ORs as they were associated with the BMI GRS.
However, we cannot exclude the possibility that BMI SNPs or the GRS are associated with asthma through unknown confounders. Results from the MR-Egger method, which is relatively robust for horizontal pleiotropy, showed consistent associations and little evidence of pleiotropy with ever asthma and doctor diagnosed asthma. In addition, the heterogeneity of the 73 BMI SNPs was relatively small.
Nevertheless, our study has several limitations. Weak instrument bias and lack of study power were possible, particularly in the evaluation of the WHR-asthma relationship. The MR-Egger intercept suggested horizontal pleiotropic effect on doctor diagnosed active asthma, which might be explained by the effect of BMI genetic variants on wheezing 11 as it was part of the definition of doctor diagnosed active asthma. In addition, the MR studies have similar weaknesses as observational studies in terms of selection and information bias. We only included 56105 subjects (86% of the 65227 participants) who had complete information on the BMI genetic variants, BMI and asthma. Besides, the participation rate in the HUNT2 Survey was moderate (70%). The excluded (n=9124) compared with the included participants (n=56105) were relatively older, lower educated, and more physically inactive, but the proportion of BMI ≥25 kg/m 2 (60.1% vs. 60.0%) and the prevalence of ever asthma (9.4% vs. 8.9%) were similar. Overall, selection bias might be possible, but it may not largely influence the causal association of BMI with asthma. Although it showed consistent results for the three asthma definitions, misclassification of asthma cannot be ruled out due to self-report, particularly among the obese individuals 30 . It was also possible that individuals with chronic obstructive pulmonary disease (COPD) reported having asthma. About 5% of the ever asthma adults reported having cough with phlegm for at least 3 months during each of the past two years and had FEV1/FVC ratio <0.70. Anthropometric markers were objectively measured.
While minor measurement errors are assumed for weight and height, we acknowledge larger measurement errors for waist and hip circumferences 31 . Evaluation of potential effects of other adiposity markers such as fat mass may therefore improve our understanding on the underlying mechanisms of the BMI-asthma association in adults. At last, although genetic assortments happen long before the onset of disease, which indicates a temporal order in an MR study, prospective data may provide additional information.
In conclusion, our study demonstrated evidence on a similar causal association between BMI and asthma risk in women and men. The causal association seemed stronger for nonatopic asthma, but it was similar for levels of asthma symptom control. The latter suggests that increased BMI might play a role in causing rather than worsening asthma. However, there was little evidence for an association between genetically determined WHR and asthma risk and for reverse causation between asthma and adiposity in this adult population. 
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